Quantifying neutralising antibody responses against SARS-CoV-2 in dried blood spots (DBS) and paired sera
Journal article
Roper KJ. et al, (2023), Scientific Reports, 13
A multi-country analysis of COVID-19 hospitalizations by vaccination status.
Journal article
Gonçalves BP. et al, (2023), Med (New York, N.Y.), 4, 797 - 812.e2
Characteristics and outcomes of an international cohort of 600 000 hospitalized patients with COVID-19
Journal article
Kartsonaki C. et al, (2023), International Journal of Epidemiology, 52, 355 - 376
Validation of extracorporeal membrane oxygenation mortality prediction and severity of illness scores in an international COVID-19 cohort.
Journal article
Shah N. et al, (2023), Artificial organs
Alternative pathway dysregulation in tissues drives sustained complement activation and predicts outcome across the disease course in COVID-19.
Journal article
Siggins MK. et al, (2023), Immunology, 168, 473 - 492
The P323L substitution in the SARS-CoV-2 polymerase (NSP12) confers a selective advantage during infection.
Journal article
Goldswain H. et al, (2023), Genome biology, 24
An international observational study to assess the impact of the Omicron variant emergence on the clinical epidemiology of COVID-19 in hospitalised patients.
Journal article
Gonçalves BP. et al, (2022), eLife, 11
Fitting to the UK COVID-19 outbreak, short-term forecasts and estimating the reproductive number
Journal article
Keeling MJ. et al, (2022), Statistical Methods in Medical Research, 31, 1716 - 1737
Prevalence and risk factors of post-COVID-19 condition in adults and children at 6 and 12 months after hospital discharge: a prospective, cohort study in Moscow (StopCOVID).
Journal article
Pazukhina E. et al, (2022), BMC medicine, 20
A core outcome set for post-COVID-19 condition in adults for use in clinical practice and research: an international Delphi consensus study.
Journal article
Munblit D. et al, (2022), The Lancet. Respiratory medicine
Prospective validation of the 4C prognostic models for adults hospitalised with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol
Journal article
Knight SR. et al, (2022), Thorax, 77, 606 - 615
What comes next in the COVID-19 pandemic?
Journal article
Fisher D. et al, (2022), Lancet (London, England), 399, 1691 - 1692
Implementation of corticosteroids in treatment of COVID-19 in the ISARIC WHO Clinical Characterisation Protocol UK: prospective, cohort study.
Journal article
Närhi F. et al, (2022), The Lancet. Digital health, 4, e220 - e234
SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses
Journal article
Dejnirattisai W. et al, (2022), Cell, 185, 467 - 484.e15
Mapping the human genetic architecture of COVID-19
Journal article
Niemi MEK. et al, (2021), Nature, 600, 472 - 477
Importance of patient bed pathways and length of stay differences in predicting COVID-19 hospital bed occupancy in England
Journal article
Leclerc QJ. et al, (2021), BMC Health Services Research, 21
Research priorities for Long Covid: refined through an international multi-stakeholder forum
Journal article
Carson G., (2021), BMC Medicine, 19
The value of open-source clinical science in pandemic response: lessons from ISARIC
Journal article
Abbas A. et al, (2021), The Lancet Infectious Diseases, 21, 1623 - 1624
Ten months of temporal variation in the clinical journey of hospitalised patients with COVID-19: An observational cohort
Journal article
Hall MD. et al, (2021), eLife, 10
Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study
Journal article
Evans RA. et al, (2021), The Lancet Respiratory Medicine, 9, 1275 - 1287